市場調查報告書
商品編碼
980099

Filgrastim生物相似藥的全球市場 - 機會及策略 (到2030年) :COVID-19的影響與成長

Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth

出版日期: | 出版商: The Business Research Company | 英文 266 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球Filgrastim生物相似藥市場相關調查分析,市場特徵,市場規模與成長率,市場區隔,各地區、各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 Filgrastim生物相似藥市場摘要整理

第2章 目錄

第3章 圖的清單

第4章 表格的清單

第5章 報告結構

第6章 簡介

第7章 Filgrastim生物相似藥市場特徵

  • 市場定義
  • 市場區隔:各適應症
    • 腫瘤
    • 慢性疾病、自體免疫疾病
    • 血液疾病
    • 生長激素缺乏症
    • 其他
  • 市場區隔:各流通管道
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第8章 Filgrastim生物相似藥市場趨勢與策略

第9章 COVID-19對Filgrastim生物相似藥市場的影響

第10章 全球Filgrastim生物相似藥市場規模與成長率

  • 市場規模
  • 市場成長成果 (金額)
  • 市場成長預測 (金額)

第11章 全球Filgrastim生物相似藥市場區隔

  • 全球Filgrastim生物相似藥市場:各適應症,成果與預測 (金額)
  • 全球Filgrastim生物相似藥市場:各流通管道,成果與預測 (金額)

第12章 Filgrastim生物相似藥市場:各地區、各國分析

  • 全球Filgrastim生物相似藥市場:各地區,成果與預測 (金額)
  • 全球Filgrastim生物相似藥市場:各國,成果與預測 (金額)

第13章 亞太地區的Filgrastim生物相似藥市場

第14章 西歐的Filgrastim生物相似藥市場

第15章 東歐的Filgrastim生物相似藥市場

第16章 北美的Filgrastim生物相似藥市場

第17章 南美的Filgrastim生物相似藥市場

第18章 中東的Filgrastim生物相似藥市場

第19章 非洲的Filgrastim生物相似藥市場

第20章 Filgrastim生物相似藥市場競爭情形

  • 企業簡介
  • Teva Pharmaceutical Industries Ltd.
  • Novartis International AG
  • Biocon Limited
  • Intas Biopharmaceuticals
  • Dr. Reddy's Laboratories

第21章 Filgrastim生物相似藥市場上主要的收購與合併

第22章 Filgrastim生物相似藥市場機會與策略

第23章 Filgrastim生物相似藥市場:結論、建議

第24章 附錄

目錄

Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the Filgrastim Biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global Filgrastim Biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by game type, and by device.

Market Characteristics - The market characteristics section of the report defines and explains the filgrastim biosimilars market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global filgrastim biosimilars market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the filgrastim biosimilars market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2015-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global filgrastim biosimilars market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for filgrastim biosimilars companies in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global filgrastim biosimilars market is segmented into -

By Application: Oncology; Chronic and Autoimmune Diseases; Blood Disorders; Growth Hormone Deficiency; Others

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Novartis International AG; Biocon Limited; Intas Biopharmaceuticals; Dr. Reddy's Laboratories

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Filgrastim Biosimilars Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Application
    • 6.1.3. Segmentation By Distribution Channel

7. Filgrastim Biosimilars Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Application
    • 7.2.1. Oncology
    • 7.2.2. Chronic And Autoimmune Diseases
    • 7.2.3. Blood Disorders
    • 7.2.4. Growth Hormone Deficiency
    • 7.2.5. Others
  • 7.3. Market Segmentation By Distribution Channel
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies

8. Filgrastim Biosimilars Market Trends And Strategies

  • 8.1. Shift Towards Development Of Biosimilars
  • 8.2. Demand For Biosimilars In The Treatment Of Neutropenia
  • 8.3. Revised FDA Regulations To Facilitate Biosimilar Drug Development
  • 8.4. Higher Investments
  • 8.5. Growing Mergers And Acquisitions

9. COVID-19 Impact On The Filgrastim Biosimilars Market

10. Global Filgrastim Biosimilars Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2019
    • 10.2.2. Restraints On The Market 2015 - 2019
  • 10.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2019 - 2023
    • 10.3.2. Restraints On The Market 2019 - 2023

11. Global Filgrastim Biosimilars Market Segmentation

  • 11.1. Global Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Oncology
    • 11.1.2. Chronic and Autoimmune Diseases
    • 11.1.3. Blood Disorders
    • 11.1.4. Others
    • 11.1.5. Growth Hormone Deficiency
  • 11.2. Global Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Hospital Pharmacy
    • 11.2.2. Retail Pharmacy
    • 11.2.3. Online Pharmacy

12. Filgrastim Biosimilars Market, Regional And Country Analysis

  • 12.1. Global Filgrastim Biosimilars Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Filgrastim Biosimilars Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Filgrastim Biosimilars Market

  • 13.1. Asia-Pacific Filgrastim Biosimilars Market Overview
  • 13.2. Asia Pacific Filgrastim Biosimilars Market Overview
    • 13.2.1. Region Information
    • 13.2.2. Impact Of COVID-19
    • 13.2.3. Market Information
    • 13.2.4. Background Information
    • 13.2.5. Government Initiatives
    • 13.2.6. Regulations
    • 13.2.7. Regulatory Bodies
    • 13.2.8. Major Associations
    • 13.2.9. Corporate Tax Structure
    • 13.2.10. Investments
    • 13.2.11. Major Companies
  • 13.3. Asia-Pacific Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.4. Asia-Pacific Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.5. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.6. Asia-Pacific Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.7. Asia-Pacific Filgrastim Biosimilars Market: Country Analysis
  • 13.8. China Filgrastim Biosimilars Market
  • 13.9. China Filgrastim Biosimilars Market Overview
    • 13.9.1. Country Information
    • 13.9.2. Impact Of COVID-19
    • 13.9.3. Market Information
    • 13.9.4. Background Information
    • 13.9.5. Government Initiatives
    • 13.9.6. Regulations
    • 13.9.7. Regulatory Bodies
    • 13.9.8. Major Associations
    • 13.9.9. Corporate Tax Structure
    • 13.9.10. Investments
    • 13.9.11. Major Companies
  • 13.10. China Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.11. China Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.12. China Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.13. China Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.14. India Filgrastim Biosimilars Market
  • 13.15. India Filgrastim Biosimilars Market Overview
    • 13.15.1. Country Information
    • 13.15.2. Impact Of COVID-19
    • 13.15.3. Market Information
    • 13.15.4. Background Information
    • 13.15.5. Government Initiatives
    • 13.15.6. Regulations
    • 13.15.7. Regulatory Bodies
    • 13.15.8. Major Associations
    • 13.15.9. Corporate Tax Structure
    • 13.15.10. Investments
    • 13.15.11. Major Companies
  • 13.16. India Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.17. India Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.18. India Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.19. India Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.20. Japan Filgrastim Biosimilars Market
  • 13.21. Japan Filgrastim Biosimilars Market Overview
    • 13.21.1. Country Information
    • 13.21.2. Impact Of COVID-19
    • 13.21.3. Market Information
    • 13.21.4. Background Information
    • 13.21.5. Government Initiatives
    • 13.21.6. Regulations
    • 13.21.7. Regulatory Bodies
    • 13.21.8. Major Associations
    • 13.21.9. Corporate Tax Structure
    • 13.21.10. Investments
    • 13.21.11. Major Companies
  • 13.22. Japan Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.23. Japan Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.24. Japan Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.25. Japan Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.26. Australia Filgrastim Biosimilars Market
  • 13.27. Australia Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.28. Australia Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.29. Australia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.30. Australia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.31. Indonesia Filgrastim Biosimilars Market
  • 13.32. Indonesia Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.33. Indonesia Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.34. Indonesia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.35. Indonesia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.36. South Korea Filgrastim Biosimilars Market
  • 13.37. South Korea Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.38. South Korea Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.39. South Korea Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.40. South Korea Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Western Europe Filgrastim Biosimilars Market

  • 14.1. Western Europe Filgrastim Biosimilars Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Western Europe Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Western Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.6. Western Europe Filgrastim Biosimilars Market: Country Analysis
  • 14.7. UK Filgrastim Biosimilars Market
  • 14.8. UK Filgrastim Biosimilars Market Overview
    • 14.8.1. Country Information
    • 14.8.2. Impact Of COVID-19
    • 14.8.3. Market Information
    • 14.8.4. Background Information
    • 14.8.5. Government Initiatives
    • 14.8.6. Regulations
    • 14.8.7. Regulatory Bodies
    • 14.8.8. Major Associations
    • 14.8.9. Taxes Levied
    • 14.8.10. Corporate Tax Structure
    • 14.8.11. Investments
    • 14.8.12. Major Companies
  • 14.9. UK Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.10. UK Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.11. UK Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.12. UK Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.13. Germany Filgrastim Biosimilars Market
  • 14.14. Germany Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.15. Germany Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.16. Germany Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.17. Germany Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.18. France Filgrastim Biosimilars Market
  • 14.19. France Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.20. France Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.21. France Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.22. France Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Filgrastim Biosimilars Market

  • 15.1. Eastern Europe Filgrastim Biosimilars Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.3. Eastern Europe Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.4. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.6. Eastern Europe Filgrastim Biosimilars Market: Country Analysis
  • 15.7. Russia Filgrastim Biosimilars Market
  • 15.8. Russia Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.9. Russia Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.10. Russia Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.11. Russia Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. North America Filgrastim Biosimilars Market

  • 16.1. North America Filgrastim Biosimilars Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Impact Of COVID-19
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.3. North America Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.4. North America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.6. North America Filgrastim Biosimilars Market: Country Analysis
  • 16.7. USA Filgrastim Biosimilars Market
  • 16.8. USA Filgrastim Biosimilars Market Overview
    • 16.8.1. Country Information
    • 16.8.2. Impact Of COVID-19
    • 16.8.3. Market Information
    • 16.8.4. Background Information
    • 16.8.5. Government Initiatives
    • 16.8.6. Regulations
    • 16.8.7. Regulatory Bodies
    • 16.8.8. Major Associations
    • 16.8.9. Taxes Levied
    • 16.8.10. Corporate Tax Structure
    • 16.8.11. Investments
    • 16.8.12. Major Companies
  • 16.9. USA Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.10. USA Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.11. USA Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.12. USA Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. South America Filgrastim Biosimilars Market

  • 17.1. South America Filgrastim Biosimilars Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Impact Of COVID-19
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Major Companies
  • 17.2. South America Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. South America Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. South America Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.6. South America Filgrastim Biosimilars Market: Country Analysis
  • 17.7. Brazil Filgrastim Biosimilars Market
  • 17.8. Brazil Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.9. Brazil Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.10. Brazil Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.11. Brazil Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Middle East Filgrastim Biosimilars Market

  • 18.1. Middle East Filgrastim Biosimilars Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Impact Of COVID-19
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.3. Middle East Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.4. Middle East Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Middle East Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Africa Filgrastim Biosimilars Market

  • 19.1. Africa Filgrastim Biosimilars Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Impact Of COVID-19
    • 19.1.3. Market Information
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes Levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Major Companies
  • 19.2. Africa Filgrastim Biosimilars Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.3. Africa Filgrastim Biosimilars Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.4. Africa Filgrastim Biosimilars Market, Segmentation By Application, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Africa Filgrastim Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Global Filgrastim Biosimilars Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Teva Pharmaceutical Industries Ltd.
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Novartis International AG
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Biocon Limited
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Intas Biopharmaceuticals
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Dr. Reddy's Laboratories
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Filgrastim Biosimilars Market

  • 21.1. Biocon Biologics Signs Licensing Agreement With Evotec
  • 21.2. Samsung Bioepis Enters Into An Agreement With C-Bridge Capital
  • 21.3. Kashiv Pharma Acquired Adello Biologics
  • 21.4. Amneal Pharmaceuticals Merge With Impax Laboratories
  • 21.5. Biocon Merged With Sandoz

22. Filgrastim Biosimilars Market Opportunities And Strategies

  • 22.1. Global Filgrastim Biosimilars Market In 2023 - Countries Offering Most New Opportunities
  • 22.2. Global Filgrastim Biosimilars Market In 2023 - Segments Offering Most New Opportunities
  • 22.3. Global Filgrastim Biosimilars Market In 2023 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Filgrastim Biosimilars Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer